Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients. Scott TF, Hackett CT, Dworek DC, Schramke CJ J Neurol Sci. 2013 Jul 15; 330(1-2):27-31. Epub 2013 Apr 18. PMID: 23602794. Abstract CommentRecommendBookmarkWatch